Información:
Error:
ID
12961
Descripción
Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193024
Link
https://clinicaltrials.gov/show/NCT00193024
Palabras clave
Versiones (1)
- 7/1/16 7/1/16 -
Subido en
7 de enero de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Breast Cancer NCT00193024
Eligibility Breast Cancer NCT00193024
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00193024
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
biopsy metastasis
Item
metastatic breast cancer confirmed by biopsy.
boolean
C0005558 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
chemotherapy
Item
received no previous chemotherapy for metastatic breast cancer.
boolean
C0392920 (UMLS CUI [1])
hormone therapy
Item
prior hormonal therapy is acceptable.
boolean
C0279025 (UMLS CUI [1])
measurement, evaluation
Item
measurable or evaluable disease.
boolean
C0242485 (UMLS CUI [1])
C0220825 (UMLS CUI [2])
C0220825 (UMLS CUI [2])
performance status
Item
able to perform activities of daily living without considerable assistance
boolean
C1518965 (UMLS CUI [1])
organ function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
informed consent
Item
must be able to understand the nature of this study and give written informed consent.
boolean
C0021430 (UMLS CUI [1])
age
Item
age < 18 years.
boolean
C0001779 (UMLS CUI [1])
cardiac ejection fraction
Item
cardiac ejection fraction < 45%.
boolean
C0232174 (UMLS CUI [1])
pregnancy, lactating
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
C2828358 (UMLS CUI [2])
meningeal metastasis
Item
patients with meningeal metastases are ineligible.
boolean
C0027627 (UMLS CUI [1,1])
C0025284 (UMLS CUI [1,2])
C0025284 (UMLS CUI [1,2])
peripheral neuropathy
Item
moderate peripheral neuropathy
boolean
C0031117 (UMLS CUI [1])
hypersensitivity
Item
history of hypersensitivity reaction to taxotere
boolean
C0020517 (UMLS CUI [1,1])
C0699967 (UMLS CUI [1,2])
C0699967 (UMLS CUI [1,2])
gender
Item
males with metastatic breast cancer
boolean
C0079399 (UMLS CUI [1])
additional inclusion/exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean